![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, June 03, 2014 11:50:54 AM
I've been doing a bit of basic modeling and I'm coming up with following...
Assumptions: profit margin of 50%, tax 30%, p/e 18.5, discount rate of 10%.
Otrexup sales: using Ali Yasar sales trajectory numbers
QST: no sales til 2017, at which time they sell $50M (1% of ATRS projected Testosterone market potential of $5B in 2017)
2015
Rev = 125M
Profit = 44M
Shs o/s = 136M
Px = 5.5
2016
Rev = 285M
Profit = 100M
Shs o/s = 138M
Px = 11.1
2017
Rev = 370M
Profit = 130M
Shs o/s = 140M
Px = 12.9
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM